Checkpoint Inhibitor Increases Head and Neck Cancer Survival Time
The checkpoint inhibitor pembrolizumab (Keytruda) offers patients with advanced head and neck cancers longer survival time, according to researchers led by the Yale.
Industry News
Industry News
Rock Star and Oral Cancer Survivor Launches Immunotherapy Fundraiser
Drummer Rikki Rockett has a different outlook on life as he heads out on tour with his band Poison this spring. A year.
